首页> 美国卫生研究院文献>Frontiers in Oncology >Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
【2h】

Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model

机译:在颅内小鼠脑胶质瘤模型中单次放射剂量后每日抗坏血酸的药理作用可保护肿瘤免受放射损伤。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pharmacological ascorbate is currently used as an anti-cancer treatment, potentially in combination with radiation therapy, by integrative medicine practitioners. In the acidic, metal-rich tumor environment, ascorbate acts as a pro-oxidant, with a mode of action similar to that of ionizing radiation; both treatments kill cells predominantly by free radical-mediated DNA damage. The brain tumor, glioblastoma multiforme (GBM), is very resistant to radiation; radiosensitizing GBM cells will improve survival of GBM patients. Here, we demonstrate that a single fraction (6 Gy) of radiation combined with a 1 h exposure to ascorbate (5 mM) sensitized murine glioma GL261 cells to radiation in survival and colony-forming assays in vitro. In addition, we report the effect of a single fraction (4.5 Gy) of whole brain radiation combined with daily intraperitoneal injections of ascorbate (1 mg/kg) in an intracranial GL261 glioma mouse model. Tumor-bearing C57BL/6 mice were divided into four groups: one group received a single dose of 4.5 Gy to the brain 8 days after tumor implantation, a second group received daily intraperitoneal injections of ascorbate (day 8–45) after implantation, a third group received both treatments and a fourth control group received no treatment. While radiation delayed tumor progression, intraperitoneal ascorbate alone had no effect on tumor progression. Tumor progression was faster in tumor-bearing mice treated with radiation and daily ascorbate than in those treated with radiation alone. Histological analysis showed less necrosis in tumors treated with both radiation and ascorbate, consistent with a radio-protective effect of ascorbate in vivo. Discrepancies between our in vitro and in vivo results may be explained by differences in the tumor microenvironment, which determines whether ascorbate remains outside the cell, acting as a pro-oxidant, or whether it enters the cells and acts as an anti-oxidant.
机译:目前,中西医结合药理学抗坏血酸被用作抗癌治疗方法,有可能与放射疗法结合使用。在酸性,富含金属的肿瘤环境中,抗坏血酸起着氧化剂的作用,其作用方式与电离辐射相似。两种疗法主要通过自由基介导的DNA损伤杀死细胞。脑肿瘤,多形性胶质母细胞瘤(GBM),对放射线非常有抵抗力。放射增敏性GBM细胞将改善GBM患者的存活率。在这里,我们证明了在存活和集落形成测定中,辐射的单部分(6 Gy)与抗坏血酸(5 mM)的1 h暴露可使鼠神经胶质瘤GL261细胞对放射敏感。此外,我们报告了在颅内GL261胶质瘤小鼠模型中,全脑放射的单一比例(4.5 Gy)联合腹膜内每天注射抗坏血酸(1 mg / kg)的效果。荷瘤C57BL / 6小鼠分为四组:一组在肿瘤植入后8天接受单剂量4.5μGy的大脑,第二组在植入后每天接受腹膜内抗坏血酸注射(第8-45天),第三组接受了两种治疗,第四对照组没有接受治疗。虽然放射线延迟了肿瘤的进展,但腹膜内抗坏血酸单独对肿瘤的进展没有影响。与单独接受放射治疗的小鼠相比,接受放射治疗和每日抗坏血酸治疗的荷瘤小鼠的肿瘤进展更快。组织学分析显示,既接受放射治疗又接受抗坏血酸治疗的肿瘤坏死较少,这与体内抗坏血酸盐的放射防护作用一致。我们的体外和体内结果之间的差异可以通过肿瘤微环境的差异来解释,该差异决定了抗坏血酸是否仍留在细胞外,充当促氧化剂或是否进入细胞并充当抗氧化剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号